|
시장보고서
상품코드
1786974
세계의 재택 주입 요법 시장 규모, 점유율, 동향, 산업 분석 리포트 : 유형별, 용도별, 지역별 - 시장 예측(2025-2034년)Home Infusion Therapy Market Size, Share, Trend, Industry Analysis Report By Type, By Application, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 재택 주입 요법 시장 규모는 2034년까지 833억 1,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학에 대한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
재택 수액요법 시장은 병원이나 수액센터가 아닌 환자의 집에서 정맥 또는 피하 경로로 약물을 투여하는 것을 말합니다. 이러한 접근 방식은 환자의 편의성을 높이고, 의료 비용을 절감하며, 병원내 감염 위험을 줄일 수 있습니다. 암, 면역력 저하, 위장장애 등 만성질환 증가로 인해 재택치료에 대한 수요가 급증하고 있습니다. 지불자와 의료 시스템은 입원 비용 상승을 억제하기 위해 외래 및 재택 치료 모델을 추진하고 있으며, 전통적인 임상 환경 밖에서 제공되는 수액 서비스의 채택을 강화하고 있습니다. 또한 컴팩트하고 사용하기 쉬운 주입 펌프와 원격 모니터링 및 가상 치료의 통합을 가능하게 하는 디지털 헬스 툴의 개발도 시장 성장에 기여하고 있습니다.
만성질환 관리를 위해 조정된 생물제제 및 특수 약물의 지속적인 발전으로 인해 신뢰할 수 있는 재택 수액 프로토콜의 필요성이 증가하고 있습니다. 의사의 수용과 상환의 명확성이 크게 개선되어 더 많은 환자에게 적용될 수 있게 되었습니다. 제약회사와 서비스 프로바이더는 약물전달과 지속적인 치료 관리를 묶어 환자의 순응도와 치료 결과를 향상시키기 위해 가치 기반 파트너십을 맺고 있습니다. 재택 수액치료 시장은 환자 중심의 물류와 교육을 활용한 개인화된 서비스에 점점 더 초점을 맞추었습니다.
임상적으로 수액 주입이 필요하고 잦은 내원이 부담스러운 호르몬 요법, 통증 관리, 희귀질환 치료 등 확대되는 치료 영역에서 치료 기회가 존재합니다. 원격의료와 자동 문서화 시스템의 통합은 업무 효율성을 획기적으로 개선하고, 의료 서비스 프로바이더는 진료의 질을 유지하면서 대량의 환자를 관리할 수 있게 됩니다. 재택 수액은 장기 치료 전략과 분산형 의료 서비스 제공의 중요한 요소로 계속 진화하고 있습니다.
재택 수액 요법 시장 보고서의 주요 내용
유형별로는 재택 환경에서 숙련된 간호사, 약국 지원 및 현장 관리 전문 지식에 대한 수요가 증가함에 따라 2024년 서비스 부문이 72%의 매출 점유율을 차지할 것으로 예측됩니다.
용도별로는 외래 환자의 골수염, 봉와직염, 심내막염과 같은 감염성 질환을 치료하기 위해 정맥내 항생제 투여가 널리 사용됨에 따라 2024년 항감염증 부문이 가장 큰 매출 점유율을 차지할 것으로 예측됩니다.
북미는 탄탄한 의료 인프라, 보험 보급, 장기 요양을 필요로 하는 고령화로 인해 2024년 재택 수액 요법 시장 매출의 57%를 차지할 것으로 예측됩니다.
아시아태평양 시장은 헬스케어에 대한 인식 증가, 도시화, 의료 분산화 노력으로 인해 2025-2034년 사이에 크게 성장할 것으로 예측됩니다.
세계의 주요 기업에는 Amedisys, Inc., B. Braun SE, Baxter, BD, CareCentrix, Inc., Coram LLC., Fresenius Kabi AG, ICU Medical, Inc., JMS Co.Ltd., Moog Inc., Option Care Health, Inc., PharMerica Corporation, Terumo Corporation 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 조사 방법
제4장 세계의 재택 주입 요법 시장 인사이트
- 시장 스냅숏
- 재택 주입 요법 시장 역학
- 촉진요인과 기회
- 만성질환의 유병률 상승
- 장기 치료를 필요로 하는 고령화 사회
- 억제요인과 과제
- 주입 장비의 고비용
- 촉진요인과 기회
- PESTEL 분석
- 재택 주입 요법 시장의 용도 동향
- 밸류체인 분석
제5장 세계의 재택 주입 요법 시장 : 유형별
- 주요 조사 결과
- 서론
- 제품
- 서비스
제6장 세계의 재택 주입 요법 시장 : 용도별
- 주요 조사 결과
- 서론
- 항감염증
- 내분비학
- 수분 보급 요법
- 화학요법
- 경장영양
- 정맥 영양
- 전문 의약품
- 기타
제7장 세계의 재택 주입 요법 시장 : 지역별
- 주요 조사 결과
- 서론
- 재택 주입 요법 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 사업 확대·인수 분석
- 사업 확대
- 인수
- 제휴/협업/협정/공개
제9장 기업 개요
- Amedisys, Inc.
- B. Braun SE.
- Baxter
- BD
- CareCentrix, Inc.
- Coram LLC.
- Fresenius Kabi AG
- ICU Medical, Inc.
- JMS Co. Ltd.
- Moog Inc.
- Option Care Health, Inc.
- PharMerica Corporation
- Terumo Corporation
The home infusion therapy market size is expected to reach USD 83.31 billion by 2034, according to a new study by Polaris Market Research. The report "Home Infusion Therapy Market Size, Share, Trend, Industry Analysis Report By Type (Product, Service), By Application (Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition), By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The home infusion therapy market refers to the administration of medications through intravenous or subcutaneous routes in a patient's home setting, rather than in hospitals or infusion centers. This approach supports patient convenience, lowers healthcare costs, and reduces hospital-acquired infection risks. The increasing prevalence of chronic diseases such as cancer, immune deficiencies, and gastrointestinal disorders has accelerated demand for home-based treatment alternatives. Payers and healthcare systems are pushing for outpatient and home care models to curb rising inpatient costs, reinforcing adoption of infusion services delivered outside traditional clinical settings. The market growth is also supported by the development of compact, user-friendly infusion pumps and digital health tools that enable remote monitoring and virtual care integration.
Ongoing advancements in biologics and specialty drugs tailored for chronic disease management boost the need for reliable home infusion protocols. Physician acceptance and reimbursement clarity have significantly improved, enabling broader patient eligibility. Pharmaceutical companies and service providers are forming value-based partnerships to bundle drug delivery with ongoing care management, enhancing patient adherence and therapeutic outcomes. The home infusion therapy market is witnessing increased focus on service personalization, leveraging patient-centric logistics and education.
Opportunities exist in expanding therapeutic areas, including hormonal therapies, pain management, and rare disease treatments, where infusion is clinically required and frequent hospital visits are burdensome. The integration of telehealth and automated documentation systems is transforming operational efficiency, allowing providers to manage high patient volumes while maintaining care quality. Home infusion continues to evolve as a key component in long-term care strategies and decentralized healthcare delivery.
Home Infusion Therapy Market Report Highlights
By type, the service segment accounted for ~72% of the revenue share in 2024, due to the growing need for skilled nursing, pharmacy support, and on-site administration expertise in home settings.
Based on application, the anti-infective segment accounted for the largest revenue share in 2024, due to the widespread use of intravenous antibiotics to treat infections such as osteomyelitis, cellulitis, and endocarditis in outpatient settings.
North America accounted for ~57% share of the home infusion therapy market revenue in 2024 due to strong healthcare infrastructure, widespread insurance coverage, and an aging population requiring long-term care.
The Asia Pacific market is expected to grow significantly from 2025 to 2034 due to rising healthcare awareness, urbanization, and efforts to decentralize medical care.
A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.
Polaris Market Research has segmented the home infusion therapy market on the basis of type, application, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Product
Infusion Pumps
Elastomeric
Electromechanical
Gravity
Others
Intravenous Sets
IV Cannulas
Needleless Connectors
Services
By Application Outlook (Revenue, USD Billion, 2020-2034)
Anti-Infective
Endocrinology
Diabetes
Others
Hydration Therapy
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Home Infusion Therapy Market Insights
- 4.1. Home Infusion Therapy Market - Market Snapshot
- 4.2. Home Infusion Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic Diseases
- 4.2.1.2. Aging Population Requiring Long-Term Therapy
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High costs of infusion equipment
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Home Infusion Therapy Market Application Trends
- 4.6. Value Chain Analysis
5. Global Home Infusion Therapy Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 5.3. Product
- 5.3.1. Global Home Infusion Therapy Market, by Product, by Region, 2020-2034 (USD Billion)
- 5.3.2. Infusion Pumps
- 5.3.2.1. Global Home Infusion Therapy Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
- 5.3.2.2. Elastomeric
- 5.3.2.2.1. Global Home Infusion Therapy Market, by Elastomeric, by Region, 2020-2034 (USD Billion)
- 5.3.2.3. Electromechanical
- 5.3.2.3.1. Global Home Infusion Therapy Market, by Electromechanical, by Region, 2020-2034 (USD Billion)
- 5.3.2.4. Gravity
- 5.3.2.4.1. Global Home Infusion Therapy Market, by Gravity, by Region, 2020-2034 (USD Billion)
- 5.3.2.5. Others
- 5.3.2.5.1. Global Home Infusion Therapy Market, by Others, by Region, 2020-2034 (USD Billion)
- 5.3.3. Intravenous Sets
- 5.3.3.1. Global Home Infusion Therapy Market, by Home Infusion Therapy Therapeutics, by Region, 2020-2034 (USD Billion)
- 5.3.4. IV Cannulas
- 5.3.4.1. Global Home Infusion Therapy Market, by IV Cannulas, by Region, 2020-2034 (USD Billion)
- 5.3.5. Needleless Connectors
- 5.3.5.1. Global Home Infusion Therapy Market, by Needleless Connectors, by Region, 2020-2034 (USD Billion)
- 5.4. Services
- 5.4.1. Global Home Infusion Therapy Market, by Personalized Medical Care, by Region, 2020-2034 (USD Billion)
6. Global Home Infusion Therapy Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 6.3. Anti-Infective
- 6.3.1. Global Home Infusion Therapy Market, by Anti-Infective, by Region, 2020-2034 (USD Billion)
- 6.4. Endocrinology
- 6.4.1. Global Home Infusion Therapy Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
- 6.4.2. Diabetes
- 6.4.2.1. Global Home Infusion Therapy Market, by Diabetes, by Region, 2020-2034 (USD Billion)
- 6.4.3. Others
- 6.4.3.1. Global Home Infusion Therapy Market, by Others, by Region, 2020-2034 (USD Billion)
- 6.5. Hydration Therapy
- 6.5.1. Global Home Infusion Therapy Market, by Hydration Therapy, by Region, 2020-2034 (USD Billion)
- 6.6. Chemotherapy
- 6.6.1. Global Home Infusion Therapy Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
- 6.7. Enteral Nutrition
- 6.7.1. Global Home Infusion Therapy Market, by Enteral Nutrition, by Region, 2020-2034 (USD Billion)
- 6.8. Parenteral Nutrition
- 6.8.1. Global Home Infusion Therapy Market, by Parenteral Nutrition, by Region, 2020-2034 (USD Billion)
- 6.9. Specialty Pharmaceuticals
- 6.9.1. Global Home Infusion Therapy Market, by Specialty Pharmaceuticals, by Region, 2020-2034 (USD Billion)
- 6.10. Others
- 6.10.1. Global Home Infusion Therapy Market, by Othersr, by Region, 2020-2034 (USD Billion)
7. Global Home Infusion Therapy Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Home Infusion Therapy Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Home Infusion Therapy Market - North America
- 7.3.1. North America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.3.2. North America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Home Infusion Therapy Market - U.S.
- 7.3.3.1. U.S.: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Home Infusion Therapy Market - Canada
- 7.3.4.1. Canada: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.3.5. Home Infusion Therapy Market - Mexico
- 7.3.5.1. Mexico: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.3.5.2. Mexico: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4. Home Infusion Therapy Market - Europe
- 7.4.1. Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.2. Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Home Infusion Therapy Market - UK
- 7.4.3.1. UK: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Home Infusion Therapy Market - France
- 7.4.4.1. France: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.4.2. France: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Home Infusion Therapy Market - Germany
- 7.4.5.1. Germany: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Home Infusion Therapy Market - Italy
- 7.4.6.1. Italy: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Home Infusion Therapy Market - Spain
- 7.4.7.1. Spain: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Home Infusion Therapy Market - Netherlands
- 7.4.8.1. Netherlands: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Home Infusion Therapy Market - Russia
- 7.4.9.1. Russia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Home Infusion Therapy Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5. Home Infusion Therapy Market - Asia Pacific
- 7.5.1. Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Home Infusion Therapy Market - China
- 7.5.3.1. China: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.3.2. China: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Home Infusion Therapy Market - India
- 7.5.4.1. India: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.4.2. India: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Home Infusion Therapy Market - Malaysia
- 7.5.5.1. Malaysia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Home Infusion Therapy Market - Japan
- 7.5.6.1. Japan: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Home Infusion Therapy Market - Indonesia
- 7.5.7.1. Indonesia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Home Infusion Therapy Market - South Korea
- 7.5.8.1. South Korea: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Home Infusion Therapy Market - Australia
- 7.5.9.1. Australia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Home Infusion Therapy Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6. Home Infusion Therapy Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Home Infusion Therapy Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Home Infusion Therapy Market - UAE
- 7.6.4.1. UAE: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Home Infusion Therapy Market - Israel
- 7.6.5.1. Israel: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Home Infusion Therapy Market - South Africa
- 7.6.6.1. South Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Home Infusion Therapy Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.7. Home Infusion Therapy Market - Latin America
- 7.7.1. Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Home Infusion Therapy Market - Brazil
- 7.7.3.1. Brazil: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.7.3.2. Brazil: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Home Infusion Therapy Market - Argentina
- 7.7.4.1. Argentina: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.7.4.2. Argentina: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Home Infusion Therapy Market - Rest of Latin America
- 7.7.5.1. Rest of Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
- 7.7.5.2. Rest of Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Amedisys, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. B. Braun SE.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Baxter
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. BD
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. CareCentrix, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Coram LLC.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Fresenius Kabi AG
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. ICU Medical, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. JMS Co. Ltd.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Moog Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Option Care Health, Inc.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. PharMerica Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Terumo Corporation
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
